Detailed information for compound 113582

Basic information

Technical information
  • TDR Targets ID: 113582
  • Name: 3-diphenylphosphanylbutan-2-yl(diphenyl)phosp hane
  • MW: 426.469 | Formula: C28H28P2
  • H donors: 0 H acceptors: 0 LogP: 6.74 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(P(c1ccccc1)c1ccccc1)C(P(c1ccccc1)c1ccccc1)C
  • InChi: 1S/C28H28P2/c1-23(29(25-15-7-3-8-16-25)26-17-9-4-10-18-26)24(2)30(27-19-11-5-12-20-27)28-21-13-6-14-22-28/h3-24H,1-2H3
  • InChiKey: FWXAUDSWDBGCMN-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • (2-diphenylphosphanyl-1-methyl-propyl)-diphenyl-phosphane
  • (2-diphenylphosphino-1-methylpropyl)-diphenylphosphane
  • (2-diphenylphosphino-1-methyl-propyl)-diphenyl-phosphane
  • 3-di(phenyl)phosphanylbutan-2-yl-di(phenyl)phosphane
  • [2-di(phenyl)phosphanyl-1-methyl-propyl]-di(phenyl)phosphane
  • [2-di(phenyl)phosphanyl-1-methylpropyl]-di(phenyl)phosphane

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus granulosus proteasome prosome macropain 0.1002 1 1
Onchocerca volvulus Notchless protein homolog 0.0076 0 0.5
Trichomonas vaginalis Family T1, proteasome beta subunit, threonine peptidase 0.1002 1 1
Echinococcus granulosus gamma secretase subunit aph 1 0.0238 0.1759 0.1759
Toxoplasma gondii proteasome subunit beta type, putative 0.1002 1 1
Brugia malayi gamma-secretase subunit aph-1 0.0238 0.1759 0.1759
Trypanosoma cruzi Aph-1 protein, putative 0.0093 0.0188 0.0188
Trypanosoma cruzi Aph-1 protein, putative 0.0093 0.0188 0.0188
Leishmania major proteasome beta 5 subunit, putative 0.1002 1 1
Entamoeba histolytica proteasome subunit beta type 5 precursor, putative 0.1002 1 1
Trypanosoma cruzi proteasome subunit beta type-5, putative 0.1002 1 1
Mycobacterium ulcerans proteasome PrcB 0.1002 1 1
Schistosoma mansoni proteasome catalytic subunit 3 (T01 family) 0.1002 1 1
Trypanosoma cruzi proteasome subunit beta type-5, putative 0.1002 1 1
Mycobacterium leprae proteasome (beta subunit) PrcB 0.1002 1 1
Loa Loa (eye worm) proteasome A-type and B-type family protein 0.1002 1 1
Plasmodium vivax proteasome subunit beta type-5, putative 0.1002 1 1
Wolbachia endosymbiont of Brugia malayi ATP-dependent protease peptidase subunit 0.0076 0 0.5
Loa Loa (eye worm) gamma-secretase subunit aph-1 0.0238 0.1759 0.1759
Trypanosoma brucei Aph-1 protein, putative 0.0093 0.0188 0.0188
Echinococcus multilocularis proteasome (prosome, macropain) 0.1002 1 1
Trypanosoma brucei proteasome subunit beta type-5, putative 0.1002 1 1
Schistosoma mansoni gamma-secretase subunit aph-1 0.0238 0.1759 0.1759
Plasmodium falciparum proteasome subunit beta type-5 0.1002 1 1
Giardia lamblia Proteasome subunit beta type 5 precursor 0.1002 1 1
Mycobacterium tuberculosis Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. 0.1002 1 1
Echinococcus multilocularis gamma secretase subunit aph 1 0.0238 0.1759 0.1759

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 50 uM In vitro cytotoxicity against murine B16 melanoma cells ChEMBL. 3681888
IC50 (functional) = 50 uM In vitro cytotoxicity against murine B16 melanoma cells ChEMBL. 3681888
ILSmax (functional) = 73 Maximum increase in life span was determined against P388 leukemia at 4-5 doses of compound ChEMBL. 3681888
MTD (functional) = 113 uM kg-1 Maximally tolerated dose was measured after ip administration of compound, 24 hr after tumor implantation. ChEMBL. 3681888
MTD (functional) = 113 uM kg-1 Maximally tolerated dose was measured after ip administration of compound, 24 hr after tumor implantation. ChEMBL. 3681888

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.